COGENT BIOSCIENCES INC (COGT) Fundamental Analysis & Valuation

NASDAQ:COGT • US19240Q2012

Current stock price

35.41 USD
+2.03 (+6.08%)
At close:
35.41 USD
0 (0%)
After Hours:

This COGT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. COGT Profitability Analysis

1.1 Basic Checks

  • COGT had negative earnings in the past year.
  • In the past year COGT has reported a negative cash flow from operations.
  • In the past 5 years COGT always reported negative net income.
  • COGT had a negative operating cash flow in each of the past 5 years.
COGT Yearly Net Income VS EBIT VS OCF VS FCFCOGT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M -200M -250M

1.2 Ratios

  • With a decent Return On Assets value of -29.63%, COGT is doing good in the industry, outperforming 67.44% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -43.65%, COGT is in the better half of the industry, outperforming 68.21% of the companies in the same industry.
Industry RankSector Rank
ROA -29.63%
ROE -43.65%
ROIC N/A
ROA(3y)-52.45%
ROA(5y)-51.98%
ROE(3y)-64.46%
ROE(5y)-60.69%
ROIC(3y)N/A
ROIC(5y)N/A
COGT Yearly ROA, ROE, ROICCOGT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for COGT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
COGT Yearly Profit, Operating, Gross MarginsCOGT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. COGT Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, COGT has more shares outstanding
  • Compared to 5 years ago, COGT has more shares outstanding
  • The debt/assets ratio for COGT is higher compared to a year ago.
COGT Yearly Shares OutstandingCOGT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
COGT Yearly Total Debt VS Total AssetsCOGT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • COGT has an Altman-Z score of 8.93. This indicates that COGT is financially healthy and has little risk of bankruptcy at the moment.
  • COGT has a better Altman-Z score (8.93) than 81.31% of its industry peers.
  • COGT has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
  • COGT has a Debt to Equity ratio of 0.35. This is in the lower half of the industry: COGT underperforms 68.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z 8.93
ROIC/WACCN/A
WACCN/A
COGT Yearly LT Debt VS Equity VS FCFCOGT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 14.23 indicates that COGT has no problem at all paying its short term obligations.
  • COGT's Current ratio of 14.23 is amongst the best of the industry. COGT outperforms 90.75% of its industry peers.
  • COGT has a Quick Ratio of 14.23. This indicates that COGT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 14.23, COGT belongs to the top of the industry, outperforming 90.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 14.23
Quick Ratio 14.23
COGT Yearly Current Assets VS Current LiabilitesCOGT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. COGT Growth Analysis

3.1 Past

  • The earnings per share for COGT have decreased by -8.60% in the last year.
EPS 1Y (TTM)-8.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-391.21%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 31.11% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-0.99%
EPS Next 2Y35.06%
EPS Next 3Y36.32%
EPS Next 5Y31.11%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COGT Yearly Revenue VS EstimatesCOGT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
COGT Yearly EPS VS EstimatesCOGT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5

More info and screens

Find the best growth stocksShow best growing peers

1

4. COGT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for COGT. In the last year negative earnings were reported.
  • Also next year COGT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
COGT Price Earnings VS Forward Price EarningsCOGT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COGT Per share dataCOGT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

  • COGT's earnings are expected to grow with 36.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.06%
EPS Next 3Y36.32%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. COGT Dividend Analysis

5.1 Amount

  • No dividends for COGT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

COGT Fundamentals: All Metrics, Ratios and Statistics

COGENT BIOSCIENCES INC

NASDAQ:COGT (3/23/2026, 8:00:01 PM)

After market: 35.41 0 (0%)

35.41

+2.03 (+6.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-17
Earnings (Next)05-04
Inst Owners105.64%
Inst Owner Change12.39%
Ins Owners0.86%
Ins Owner Change63.27%
Market Cap5.75B
Revenue(TTM)N/A
Net Income(TTM)-277.80M
Analysts85.26
Price Target52.96 (49.56%)
Short Float %10.06%
Short Ratio7.94
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.56%
Min EPS beat(2)-12.23%
Max EPS beat(2)7.11%
EPS beat(4)3
Avg EPS beat(4)4.8%
Min EPS beat(4)-12.23%
Max EPS beat(4)12.87%
EPS beat(8)4
Avg EPS beat(8)8.51%
EPS beat(12)5
Avg EPS beat(12)2.86%
EPS beat(16)6
Avg EPS beat(16)-0.08%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.47%
PT rev (3m)5.76%
EPS NQ rev (1m)-23.01%
EPS NQ rev (3m)-23.01%
EPS NY rev (1m)0%
EPS NY rev (3m)0.71%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 9.03
P/tB 9.03
EV/EBITDA N/A
EPS(TTM)-2.14
EYN/A
EPS(NY)-2.16
Fwd EYN/A
FCF(TTM)-1.28
FCFYN/A
OCF(TTM)-1.28
OCFYN/A
SpS0
BVpS3.92
TBVpS3.92
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -29.63%
ROE -43.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-52.45%
ROA(5y)-51.98%
ROE(3y)-64.46%
ROE(5y)-60.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 23.39%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.23
Quick Ratio 14.23
Altman-Z 8.93
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)321.08%
Cap/Depr(5y)421.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-391.21%
EPS Next Y-0.99%
EPS Next 2Y35.06%
EPS Next 3Y36.32%
EPS Next 5Y31.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year0.3%
EBIT Next 3Y7.72%
EBIT Next 5Y26.19%
FCF growth 1Y-33.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.26%
OCF growth 3YN/A
OCF growth 5YN/A

COGENT BIOSCIENCES INC / COGT Fundamental Analysis FAQ

What is the fundamental rating for COGT stock?

ChartMill assigns a fundamental rating of 2 / 10 to COGT.


Can you provide the valuation status for COGENT BIOSCIENCES INC?

ChartMill assigns a valuation rating of 1 / 10 to COGENT BIOSCIENCES INC (COGT). This can be considered as Overvalued.


What is the profitability of COGT stock?

COGENT BIOSCIENCES INC (COGT) has a profitability rating of 1 / 10.